Long-term improvement of anaemia in a patient with aplastic anaemia by short-term administration of pegylated recombinant human megakaryocyte growth and development factor

Br J Haematol. 2004 Jun;125(6):818-9. doi: 10.1111/j.1365-2141.2004.04980.x.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anemia, Aplastic / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Polyethylene Glycols / therapeutic use*
  • Recombinant Proteins / therapeutic use*
  • Thrombopoietin / therapeutic use*
  • Time Factors

Substances

  • Recombinant Proteins
  • polyethylene glycol-recombinant human megakaryocyte growth and development factor
  • Polyethylene Glycols
  • Thrombopoietin